echoloc

Alkermes Tech Stack

Neuroscience-focused biopharmaceutical company developing treatments for psychiatric and neurological disorders

Biotechnology Research Dublin 1,001–5,000 employees Founded 1987 Public Company

Alkermes is a publicly traded biopharmaceutical company applying neuroscience expertise to develop medicines for psychiatric, neurological, and addiction-related disorders. The tech stack reveals a traditional pharma operations spine—Veeva (Vault, RIM, PromoMats), SAP, Oracle—paired with emerging analytics and manufacturing modernization (adopting MES and LIMS). Active hiring spans sales (largest cohort), manufacturing, research, and clinical development, with notable leadership gaps in medical direction and IT R&D, signaling investment in regulatory strategy, clinical trial design, and manufacturing process control.

Tech Stack 69 technologies

Core StackJava Python SAP Oracle AWS SAS Salesforce Veeva Vault JMP SQL HTML Excel Veeva RIM Maximo Microsoft Office Blender HMI Rockwell FactoryTalk Purview Proofpoint Veeva PromoMats Azure SAP Concur Synthesia R CDISC Outlook PowerPoint Rockwell Automation Word+32 more
AdoptingMES LIMS

What Alkermes Is Building

Challenges

  • Reducing waste and increasing process reliability
  • Increasing product usage
  • Identifying data gaps
  • Ensuring labeling compliance
  • Regulatory submissions management
  • Compliance with gmp and gxp
  • Reducing equipment downtime
  • Identifying opportunities and barriers
  • Cross-functional coordination
  • Fiscal control of operational expenses

Active Projects

  • Technology transfer
  • Cmc regulatory strategy for development programs
  • Protocol design for clinical trials
  • Dashboard development using r shiny
  • Market access field reimbursement strategy development
  • Educational program implementation for access and reimbursement
  • Facility/utility improvement projects
  • Clinical trial quantitative decision-making support
  • Indigo program
  • Clinical development strategy

Hiring Activity

Steady120 roles · 50 in 30d

Department

Sales
34
Manufacturing
15
Research
14
Engineering
11
Marketing
10
Ops
7
Healthcare
6
Data
5

Seniority

Senior
27
Director
26
Mid
23
Manager
15
Junior
12
Intern
9
Lead
7
VP
2

Notable leadership hires: Medical Director, Marketing Director, IT R&D Director

Company intelligence

Find more companies like Alkermes by tech stack, pain points and active projects

Get started free

About Alkermes

Alkermes develops and commercializes medicines for complex psychiatric and neurological conditions including addiction, serious mental illness, and sleep disorders. The company operates across three core areas: clinical development (protocol design, quantitative decision-making for trials), regulatory and compliance (CMC strategy, GMP/GxP adherence, labeling), and commercial access (field reimbursement, patient education programs). At 1,001–5,000 employees with headquarters in Dublin and operations across Ireland, the United States, and the United Kingdom, Alkermes balances R&D intensity with manufacturing and commercial infrastructure. Active pain points center on process reliability, regulatory submissions management, cross-functional coordination, and operational cost control—typical challenges for mid-scale pharma navigating clinical pipeline advancement and manufacturing scale-up.

HeadquartersDublin
Company Size1,001–5,000 employees
Founded1987
Hiring MarketsUnited Kingdom, United States, Ireland

Frequently Asked Questions

What tech stack does Alkermes use?

Veeva Vault, Veeva RIM, and Veeva PromoMats for pharma-specific workflows; SAP and Oracle for enterprise operations; AWS and Azure for cloud compute; SQL, Python, R, and JMP for data analysis; Salesforce for commercial; Rockwell Automation and Maximo for manufacturing.

Where is Alkermes headquartered?

Dublin, Ireland. The company was founded in 1987 and is publicly traded. Active hiring spans Ireland, the United States, and the United Kingdom.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size